Macrophage migration inhibitory factor: An intracellular inhibitor of angiotensin II-induced increases in neuronal activity

Journal of Neuroscience

Volumn 24, Issue 44, 2004, Pages 9944-9952

  Sun, Chengwen ^a   Li, Hongwei ^a   Leng, Lin ^b   Raizada, Mohan K ^a   Bucala, Richard ^b   Sumners, Colin ^a,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; Firing rate; Macrophage migration inhibitory factor; Neuron; Reactive oxygen species; Thiol protein oxidoreductase

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II ANTAGONIST; MACROPHAGE MIGRATION INHIBITION FACTOR; OXIDOREDUCTASE; PEPTIDE FRAGMENT; THIOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CELL ACTIVITY; CELL CULTURE; CELL MIGRATION; CELLULAR DISTRIBUTION; CHRONOTROPISM; HYPOTHALAMUS; NERVE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ACTION POTENTIALS; AMINO ACID SEQUENCE; ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; OXIDOREDUCTASES; PEPTIDE FRAGMENTS; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 7744235386     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2856-04.2004     Document Type: Article

References (47)

1. Averill DB, Diz DI (2000) Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull 51:119-128.
2. Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA, Calandra T, Gemsa D, Donnelly T, Atkins RC, Bucala R (1997) Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 150:235-246.
3. Baugh JA, Bucala R (2002) Macrophage migration inhibitory factor. Crit Care Med 30:S27-S35.
4. Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, Wolfe F, Gregersen PK, Bucala R (2002) A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 3:170-176.
5. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33:14144-14155.
6. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, David JR (1999) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189:341-346.
7. Busche S, Gallinat S, Fleegal MA, Raizada MK, Sumners C (2001) Novel role of macrophage migration inhibitory factor in angiotensin II regulation of neuromodulation in rat brain. Endocrinology 142:4623-4630.
8. Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791-800.
9. Culman J, Blume A, Gohlke P, Unger T (2002) The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers. J Hum Hypertens 16[Suppl 3]:S64-S70.
10. Dampney RA, Fontes MA, Hirooka Y, Horiuchi J, Potts PD, Tagawa T (2002) Role of angiotensin II receptors in the regulation of vasomotor neurons in the ventrolateral medulla. Clin Exp Pharmacol Physiol 29:467-472.
11. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000) International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472.
12. Donn RP, Ray DW (2004) Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 182:1-9.
13. Ferguson AV, Washburn DL, Latchford KJ (2001) Hormonal and neurotransmitter roles for angiotensin in the regulation of central autonomic function. Exp Biol Med (Maywood) 226:85-96.
14. Fingerle-Rowson GR, Bucala R (2001) Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol Cell Biol 79:368-375.
15. Fleegal MA, Sumners C (2003) Angiotensin II induction of AP-1 in neurons requires stimulation of PI3-K and JNK. Biochem Biophys Res Commun 310:470-477.
16. Gyurko R, Wielbo D, Phillips MI (1993) Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept 49:167-174.
17. Han NL, Sim MK (1998) Hypothalamic angiotensin receptor subtypes in normotensive and hypertensive rats. Am J Physiol 275:H703-H709.
18. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 95:2509-2514.
19. Huang J, Hara Y, Anrather J, Speth RC, Iadecola C, Pickel VM (2003) Angiotensin II subtype 1A (AT1A) receptors in the rat sensory vagal complex: subcellular localization and association with endogenous angiotensin. Neuroscience 122:21-36.
20. Jensen LL, Harding JW, Wright JW (1992) Role of paraventricular nucleus in control of blood pressure and drinking in rats. Am J Physiol 262:F1068-F1075.
21. Kleemann R, Kapurniotu A, Frank RW, Gessner A, Mischke R, Flieger O, Juttner S, Brunner H, Bernhagen J (1998) Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J Mol Biol 280:85-102.
22. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J (2000) Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408:211-216.
23. Kleemann R, Grell M, Mischke R, Zimmermann G, Bernhagen J (2002) Receptor binding and cellular uptake studies of macrophage migration inhibitory factor (MIF): use of biologically active labeled MIF derivatives. J Interferon Cytokine Res 22:351-363.
24. Kugler S, Meyn L, Holzmuller H, Gerhardt E, Isenmann S, Schulz JB, Bahr M (2001) Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors. Mol Cell Neurosci 17:78-96.
25. Latchford KJ, Ferguson AV (2003) Angiotensin II activates a nitric-oxide-driven inhibitory feedback in the rat paraventricular nucleus. J Neurophysiol 89:1238-1244.
26. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467-1476.
27. Li DP, Chen SR, Pan HL (2003) Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. J Neurosci 23:5041-5049.
28. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J (2002) Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect 4:449-460.
29. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, Bucala R (1995) Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 154:3863-3870.
30. Muratani H, Teruya H, Sesoko S, Takishita S, Fukiyama K (1996) Brain angiotensin and circulatory control. Clin Exp Pharmacol Physiol 23:458-464.
31. Nguyen MT, Beck J, Lue H, Funfzig H, Kleemann R, Koolwijk P, Kapurniotu A, Bernhagen J (2003a) A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions. J Biol Chem 278:33654-33671.
32. Nguyen MT, Lue H, Kleemann R, Thiele M, Tolle G, Finkelmeier D, Wagner E, Braun A, Bernhagen J (2003b) The cytokine macrophage migration inhibitory factor reduces pro-oxidative stress-induced apoptosis. J Immunol 170:3337-3347.
33. Oparil S, Yang RH, Jin HG, Chen SJ, Meng QC, Berecek KH, Wyss JM (1994) Role of anterior hypothalamic angiotensin II in the pathogenesis of salt sensitive hypertension in the spontaneously hypertensive rat. Am J Med Sci. 307[Suppl 1]:S26-S37.
34. Rice EK, Tesch GH, Cao Z, Cooper ME, Metz CN, Bucala R, Atkins RC, Nikolic-Paterson DJ (2003) Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II. Kidney Int 63:1265-1275.
35. Rosengren E, Bucala R, Aman P, Jacobsson L, Odh G, Metz CN, Rorsman H (1996) The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 2:143-149.
36. Sakai M, Nishihira J, Hibiya Y, Koyama Y, Nishi S (1994) Glutathione binding rat liver 13k protein is the homologue of the macrophage migration inhibitory factor. Biochem Mol Biol Int 33:439-446.
37. Sambrook JF, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, Chap 1. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
38. Sumners C, Tang W, Zelezna B, Raizada MK (1991) Angiotensin II receptor subtypes are coupled with distinct signal transduction mechanisms in neurons and astrocytes from rat brain. Proc Natl Acad Sci USA 88:7567-7571.
39. 2+ currents: intracellular mechanisms. Am J Physiol 271:C154-C163.
40. Sumners C, Fleegal MA, Zhu M (2002) Angiotensin AT1 receptor signalling pathways in neurons. Clin Exp Pharmacol Physiol 29:483-490.
41. Sun C, Sumners C, Raizada MK (2002) Chronotropic action of angiotensin II in neurons via protein kinase C and CaMKII. Hypertension 39:562-566.
42. Sun C, Raizada MK, Sumners C (2004) Angiotensin II-induced increases in neuronal firing: role of ROS. FASEB J 18:834.3.
43. Wang D, Gelband CH, Sumners C, Posner P (1997) Mechanisms underlying the chronotropic effect of angiotensin II on cultured neurons from rat hypothalamus and brain stem. J Neurophysiol 78:1013-1020.
44. Zhang M, Aman P, Grubb A, Panagopoulos I, Hindemith A, Rosengren E, Rorsman H (1995) Cloning and sequencing of a cDNA encoding rat D-dopachrome tautomerase. FEBS Lett 373:203-206.
45. + current: role of 12-lipoxygenase metabolites of arachidonic acid. J Neurophysiol 84:2494-2501.
46. Zhu M, Sumners C, Gelband CH, Posner P (2001) Chronotropic effect of angiotensin II via type 2 receptors in rat brain neurons. J Neurophysiol 85:2177-2183.
47. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad JM, Spitz DR, Davisson RL (2002) Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91:1038-1045.